The present invention refers to a crystalline compound of 7- (3R)-3-amirio-1-oxo-4-(2 4 5-trifluorophenyl)butylj-5 6 7 8- tetrahydro-3-(trifluoromethyl)-1 2 4-triazolo 4 3- a pyrazine (INN: Sitagliptin) of formula I with fumaric acid or a hydrate thereof where the molar ratio of the compound of formula Ito fumaric acid is 1:0.6 to